Table 5.
Group | Lean | Obese | Tesaglitazar | |||
---|---|---|---|---|---|---|
State | Basal | ClampL | Basal | ClampL | Basal | ClampL |
Body weight (g) | 407 ± 11*** | 405 ± 20 | 603 ± 14 | 582 ± 18 | 666 ± 30 | 664 ± 27 |
Insulin (nM) | 0.74 ± 0.16*** | 1.10 ± 0.10 | 5.88 ± 0.67 | 13.61 ± 2.60† | 0.67 ± 0.07*** | 2.25 ± 0.10‡ |
FFA (mM) | 0.42 ± 0.03*** | 0.08 ± 0.01 | 0.89 ± 0.05 | 0.63 ± 0.09 | 0.81 ± 0.04 | 0.10 ± 0.01‡‡ |
K fa (mL/min) | 17.4 ± 2.1 | 25.8 ± 1.5 | 20.7 ± 2.3 | 28.3 ± 1.6 | 38.4 ± 2.2*** | 47.1 ± 2.5 |
R fa (µmol/min) | 7.2 ± 1.0*** | 2.0 ± 0.1 | 18.9 ± 2.8 | 18.1 ± 3.2 | 31.0 ± 3.0* | 4.6 ± 0.5‡‡‡ |
Glucose (mM) | 7.4 ± 0.2** | 7.7 ± 0.3 | 11.1 ± 1.0 | 11.6 ± 1.3 | 11.8 ± 0.5 | 10.0 ± 0.4 |
GIR (µmol/min) | 0 | 26.1 ± 2.4 | 0 | 8.9 ± 2.7††† | 0 | 66.9 ± 9.2‡‡‡ |
(µmol/min) | 19.0 ± 2.2** | 47.6 ± 1.2 | 36.0 ± 3.5 | 41.2 ± 2.0†† | 36.2 ± 3.1 | 101.8 ± 6.9‡‡ |
Results are mean ± SE (n = 6–9). Zucker rats were studied in the 5 h fasted state. Groups of animals were studied either in the basal state or during isoglycemic clamps performed at physiological levels of hyperinsulinemia suited to each group (insulin infusion rates as for ClampL in Study 2, defined in Table 3). Basal state differences; *P < 0.05, **P < 0.01, and ***P < 0.001 versus obese. Response to insulin (ClampL-Basal) differences; † P < 0.05, †† P < 0.01, and ††† P < 0.001 Obese versus Lean, ‡ P < 0.05, ‡‡ P < 0.01, and‡‡‡ P < 0.001 Tesaglitazar versus Obese.